MKI67 and breast cancer: As is known, estrogen receptor (ER), progestogen receptor (PR), human epidermal growth factor receptor 2 (HER-2) and nuclear protein Ki67 are the main known biomarkers to evaluate the prognosis of breast cancer [25-27].